Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Vulvar Cases: A Comprehensive Review of Mucous Membrane Pemphigoid and Genitourinary Syndrome of Menopause
Description
This comprehensive review discusses two significant cases related to vulvar conditions: mucous membrane pemphigoid (MMP) and genitourinary syndrome of menopause (GSM). The first case involves an 84-year-old woman with extensive scarring, blisters, and erosions, diagnosed with MMP. Important diagnostic clues emphasized include the need to check other mucosal surfaces like the eyes and mouth, as MMP can affect various areas and manifestations may be subtle. The diagnosis often poses challenges due to frequently negative test results, necessitating thorough patient history and symptom review. Treatment primarily involves rituximab, with careful monitoring for disease progression. The second case features a 31-year-old non-binary individual experiencing discomfort following gender-affirming surgery, diagnosed with GSM, which can occur even without oophorectomy. This highlights the impact of declining estrogen levels on individuals with female anatomy, causing symptoms like vaginal dryness and discomfort. Treatment strategies for GSM include topical estradiol, particularly for trans individuals who may be hesitant about systemic hormones. Key takeaways from the session stress the importance of examining all mucosal surfaces, recognizing subtle symptoms of vulvar diseases, and understanding the specific risks for transgender individuals in relation to vulvar health.
View moreConclusions
- Mucous membrane pemphigoid (MMP) can present with varying symptoms, including bleeding, pain, incontinence, and erosions, which may be subtle in early stages.
- Diagnosis of MMP can be challenging, with many tests returning negative results despite clear clinical signs.
- A complete review of systems, including checks of all mucosal surfaces, is crucial for accurately diagnosing conditions like MMP.
- Genitourinary syndrome of menopause (GSM) can occur post-hysterectomy or oophorectomy, leading to significant changes in genital health.
- Transgender individuals, especially those undergoing hormone therapy or gender-affirming surgeries, are at increased risk for vulvar diseases and related complications.
- Early intervention and tailored treatment, such as the use of vaginal estrogen or topical therapies, can effectively improve symptoms related to GSM, especially in transgender patients.
- Rituximab is highlighted as a treatment option with good evidence for disease control and improved quality of life in MMP cases.
- Mahmood S et al, Nature BMT, 2009
- Meijer JM, Rashid H, Terra JB, AIBD, 2022
- Hokama et al, WJGE 2010
- Terra et al, BJD, 2011
- Boch K, J Dtsch Dermatol Ges 2020
- Joly E, Ann Derm Venereol 2021
- Schmidt E et al, JEADV 2021
- Rashid H et al, JEADV 2021
- Hofmann SC et al, JDDG 2022
- Zapata-Caballero, Int J Gyn Obs 2024
- Cuccu I, Life (Basel), 2024
- Danan E, GSM: A Systematic Review, 2024